Specifically, the identification of peptides that bind to both DRB1*0402 and DQB1*0503 are of great importance as these peptides may serve as targets for epitope-based therapeutic vaccination of both DR4 and DR6 PV patients. This evidence concerns the gene TNFRSF10A and acquired polycythemia vera.